Back
BioMarin Pharmaceutical, Inc. 10K Form
Sell
29
BMRN
BioMarin Pharmaceutical, Inc.
Last Price:
$55.50
Seasonality Move:
1.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-26 | 10Q | BMRN/BioMarin Pharmaceutical, Inc. Quarterly |
| 2024-02-26 | 10K | BMRN/BioMarin Pharmaceutical, Inc. Annual |
| 2023-11-02 | 10Q | BMRN/BioMarin Pharmaceutical, Inc. Quarterly |
| 2023-08-02 | 10Q | BMRN/BioMarin Pharmaceutical, Inc. Quarterly |
| 2023-04-28 | 10Q | BMRN/BioMarin Pharmaceutical, Inc. Quarterly |
| 2023-02-27 | 10K | BMRN/BioMarin Pharmaceutical, Inc. Annual |
Receive BMRN News And Ratings
See the #1 stock for the next 7 days that we like better than BMRN
BMRN Financial Statistics
Sales & Book Value
| Annual Sales: | $3.2B |
|---|---|
| Cash Flow: | $56.6M |
| Price / Cash Flow: | 14.59 |
| Annual Sales: | $31.65 |
| Price / Book: | 1.7 |
Profitability
| EPS (TTM): | 1.78170 |
|---|---|
| Net Income (TTM): | $348.9M |
| Gross Margin: | $2.5B |
| Return on Equity: | 5.89% |
| Return on Assets: | 4.74% |
BioMarin Pharmaceutical, Inc. Earnings Forecast
Key BioMarin Pharmaceutical, Inc. Financial Ratios
-
The Gross Profit Margin over the past 29 years for BMRN is 77.27%.
-
The Selling, General & Administrative Expenses for BMRN have been equal to 35.57% of Gross Profit Margin.
-
The Research & Development expenses have been 21.62% of Revenue.
-
The Interest Expense is 3.12% of Operating Income.
-
The Net Earning history of BMRN is 10.76% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 15 years.
BioMarin Pharmaceutical, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BMRN |
| CUSIP: | 09061G |
| Website: | biomarin.com |
Debt
| Debt-to-Equity Ratio: | 0.11 |
|---|---|
| Current Ratio: | 5.18 |
| Quick Ratio: | 3.25 |
Price-to-Earnings
| Trailing P/E Ratio: | 29.82 |
|---|---|
| Forward P/E Ratio: | 7.99 |
BMRN Technical Analysis vs Fundamental Analysis
Sell
29
BioMarin Pharmaceutical, Inc. (BMRN)
is a Sell
Is BioMarin Pharmaceutical, Inc. a Buy or a Sell?
-
BioMarin Pharmaceutical, Inc. stock is rated a SellThe current BioMarin Pharmaceutical, Inc. [BMRN] share price is $55.50. The Score for BMRN is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.